Navigation Links
Lilly Delivers Strong Third-Quarter Results
Date:10/18/2007

Weighted-average

shares outstanding

(thousands) -

diluted 1,090,228 1,086,412 1,090,095 1,086,449

N/M - not meaningful

Eli Lilly and Company

Operating Results (Unaudited) - PRO FORMA ADJUSTED

(Dollars in millions, except per share data)

Three Months Nine Months

Ended Sept. 30 Ended Sept. 30

2007(a)(b) 2006(b) % Chg. 2007(a)(b) 2006(b) %Chg.

---------------------------------------------------------

Net sales $4,586.8 $4,054.7 13% $13,516.6 $11,986.3 13%

Cost of sales 1,054.6 906.2 16% 2,991.9 2,663.3 12%

Research and

development 844.5 788.8 7% 2,545.1 2,370.1 7%

Marketing and

administrative 1,477.8 1,302.3 13% 4,375.2 3,886.1 13%

------- ------- ------- -------

Operating income 1,209.9 1,057.4 14% 3,604.4 3,066.8 18%

Net interest income

(expense) (6.2) (34.2) (23.4) (108.9)

Joint-venture

income - - - -

Net other income 56.0 29.4 91.8 73.4

---- ---- ---- ----

Other income

(deductions) 49.8 (4.8) 68.4 (35.5)

Income before

income taxes 1,259.7 1,052.6 20% 3,672.8 3,031.3 21%

Income taxes 263.3 220.6 19% 795.8 630.8 26%

----- ----- ----- -----

Net income $996.4 $832.0 20% $2,877.0 $2,400.5 20%

------ ------
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Animal insulin product to be discontinued by drug major Eli Lilly
2. Did Eli Lilly Turn Wily With Regard to Their Best-selling Schizophrenia Drug?
3. Eli Lilly Releases Digital Insulin Pen
4. Woman Delivers Identical Quadruplets
5. No Carrier Necessary: This Drug Delivers Itself
6. Government Delivers On Emergency Medical Training For Rural Doctors
7. Fat Screen Delivers Plant-derived Chemical With Antidiabetic Effects
8. Cuban Healthcare Delivers, Experts Say
9. Strong pain killers likely to cause miscarriage
10. Strong emotions can cause heart problems
11. Avoid stress to have strong babies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Boston, Mass.By studying the roles two proteins, thrombospondin-1 ... trans-Atlantic research team has identified a five-amino acid ... in mouse models of prostate, breast and lung ... could potentially block metastasis in a variety of ... Randolph Watnick, PhD, at Boston Children,s Hospital, Vivek ...
(Date:5/21/2013)... May 21, 2013 The nation’s first ... is nearing its conclusion in Washington state court, ... closing statements yesterday, an attorney for the Plaintiffs compared ... wanted to tie sales and services for its customers. ... to keep control of surgeons, to keep control of ...
(Date:5/21/2013)... A new study appearing in the ... stem cells harvested from fat (adipose) are more potent ... modulate the body’s immune system. , The finding ... as adipose tissue-derived stem cells (AT-SCs) are far more ... marrow and can be collected from waste material from ...
(Date:5/21/2013)... TUESDAY, May 21 (HealthDay News) -- Less is more ... severe bouts of chronic obstructive pulmonary disease (COPD), according ... with prednisone to treat COPD flare-ups was as good ... for adverse side effects, they said. "We wanted ... not less effective than 14 days," said lead researcher ...
(Date:5/21/2013)... of Iowa,s vice president for research and economic ... computing, the next generation of supercomputers designed to ... the human mind. , Daniel Reed will appear ... the House Subcommittee on Energy, titled, "America,s Next ... at 10 a.m. in Room 2318 of the ...
Breaking Medicine News(10 mins):Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3Health News:COPD Patients May Do Fine With Shorter Course of Steroids 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 3Health News:Iowa VP for Research addresses next-generation supercomputers at congressional hearing 2
... men enrolled in an active surveillance program for prostate ... fared just as well as men who opted to ... during surveillance showed high-grade cancer. Active surveillance, or ... tumors are considered small, low-grade and at low risk ...
... A psychological intervention program designed for breast cancer patients reduces ... shows. The study is the latest in a series ... program that teaches patients how to cope with the disease ... survival. Researchers at Ohio State,s Comprehensive Cancer Center had ...
... guidelines for best treatment practices are common, they ... to them in clinical practice, according to a ... medicine researchers. In the study, UC associate ... his colleagues used national standards for treatment of ...
... -- City of Hope researchers received approval from the ... first-in-human study of a neural stem cell-based therapy targeting ... tumor. Karen S. Aboody, M.D., associate professor in City ... that developed this treatment strategy. Jana Portnow, M.D., assistant ...
... the University of Cincinnati (UC) and the Cincinnati ... received funding to study the care processes that ... beginning dialysis. Timmy Lee, MD, UC Health ... the study, was awarded the National Kidney Foundation,s ...
... cats have them and whales have some, too. Neurons, those ... our spinal cords to the tips of our toes, paws ... journal Cell , scientists from the Harvard Medical School, ... found a new way by which nerve cells relay information ...
Cached Medicine News:Health News:Delay in surgery not likely to worsen tumors in men with low-risk prostate cancer 2Health News:Intervention program helps breast cancer patients live longer after recurrence 2Health News:Intervention program helps breast cancer patients live longer after recurrence 3Health News:'Knowledge translation' keeps treatment current 2Health News:FDA approves first human neural stem cell clinical trial to treat brain tumors 2Health News:FDA approves first human neural stem cell clinical trial to treat brain tumors 3Health News:New research examines care practices in place for dialysis patients 2
(Date:5/21/2013)... SANTA CLARA, Calif. , May 21, ... a game-changing embedded-ultrasound platform, today announced the ... Toolkit that allows complete network-based communications with ... demonstrate its latest embedded-ultrasound technology, including this ... Sao Paulo, Brazil ...
(Date:5/21/2013)... , May 21, 2013 Hurel Corporation ... and microfluidic cell-based assay platforms, today announced the appointment ... DABT to the Company,s Board of Directors. Dr. MacDonald ... of the Schering-Plough Research Institute ("SPRI"), which was the ... acquisition by Merck & Co. in 2009. ...
(Date:5/21/2013)... -- Vasomedical, Inc. (OTC BB: VASO) (the "Company"), a diversified medical ... medical devices and in the domestic sale of diagnostic imaging ... , President and CEO of Vasomedical, Inc. will present at ... 30, 2013 in New York City ... presentation is scheduled to begin at 9:30 a.m. EDT. ...
Breaking Medicine Technology:Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2
... 2012  Islet Sciences, Inc., (OTCBB: ISLT) a biotechnology company ... technologies in the field of transplantation therapy for patients ... technology from Yale University. "In the ... Herold and his colleagues at Yale University School of ...
... /PRNewswire-iReach/ -- PharmacyGPO, Inc.,  a ... the United States, today announced a three-year agreement ... (Photo: http://photos.prnewswire.com/prnh/20120507/CG01217 ) ... Smith, a leading national wholesaler, will be the ...
Cached Medicine Technology:Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic 2PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor 2PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor 3
Suture Cutter, straight...
Suture Cutter, 15 Up Curve...
Suture scissor...
...
Medicine Products: